Controlling neuronal pain after shingles

Phase 3

• Conditions: Zona.; Zoster [herpes zoster]

• Registration Number: IRCT20151003024317N9
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

Patients over 18 years
Post-shingle neuralgia
Not taking other medications topically and systemically two weeks before enrollment to study

Exclusion Criteria

Wounds or erosion
Infection or severe thinning of the affected skin area
Mucosal involvement
Pregnancy
Breastfeeding
Mental illness
Mental retardation

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity of pain. Timepoint: On arrival - After taking the medicine. Method of measurement: From 1 to 10 (Based on numerical scale).;Severity of drug side effects. Timepoint: After taking the medicine. Method of measurement: From 1 to 4 (Based on numerical scale).;Patient Satisfaction. Timepoint: After taking the medicine. Method of measurement: From 1 to 5 (based on Likert scale).